Form 4: Guardant Health Executive Darya Chudova Reports Stock Transactions

Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting and subsequent tax withholding of restricted stock units.

Summary

• Darya Chudova, Chief Technology Officer of Guardant Health, filed a Form 4 detailing changes in beneficial ownership of the company's stock.
• On March 1, 2025, Ms. Chudova vested 5,686 performance-based restricted stock units and 315 restricted stock units.
• The company withheld 3,042 shares to cover tax obligations related to the vesting of the restricted stock units at a price of $42.55.
• Following these transactions, Ms. Chudova directly owns 73,023 shares of Guardant Health common stock.
• She also holds 17,062 performance-based restricted stock units and 632 restricted stock units.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices and achievement of performance metrics, suggesting a neutral to slightly positive outlook.

Positives

• The vesting of restricted stock units indicates that performance metrics were achieved, which is a positive sign for the company.
• Ms. Chudova's continued holding of a significant number of shares and restricted stock units aligns her interests with those of the shareholders.

Future Outlook

The remaining 67% of the performance-based restricted stock units will vest over the following two years, with 33% vesting on January 1, 2026, and 34% vesting on January 1, 2027.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies within the healthcare and biotechnology sectors.

Comparison to Industry Standards

• Executive compensation packages including restricted stock units are standard practice in the biotechnology industry.
• Companies like Illumina, Roche, and Exact Sciences also utilize stock-based compensation to align executive interests with shareholder value.
• The vesting schedules and performance-based criteria are typical for incentivizing long-term growth and achievement of strategic goals.

Stakeholder Impact

• Shareholders may view the vesting of performance-based restricted stock units as a positive indicator of company performance.
• Employees may be motivated by the potential for similar stock-based compensation.

Key Dates